Status:
COMPLETED
Effect of Zinc Supplementation on Depression in SSRI-treated Major Depressive Disorder Patients
Lead Sponsor:
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Conditions:
MDD
Eligibility:
All Genders
18-55 years
Phase:
NA
Brief Summary
Title: Effect of zinc supplementation on depression in SSRIs-treated MDD patients. Purpose: Depression is the single largest contributor to global disability as has been ranked by WHO (2015), in hum...
Detailed Description
Depression (MDD) is a major global health problem. The number of people suffering from major depressive disorder was reported as around 300 million (about 4.4% of the world's population) in 2015. The ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Newly diagnosed patients with major depressive disorder diagnosed from the Psychiatry department of BSMMU according to the diagnostic protocol which fulfills DSM-4 criteria and SCID 1 Bangla version.
- Patients treated with only SSRIs.
- Mild to moderate MDD patients.
- Age: 18-55 years.
- Sex: Both male and female.
- Exclusion criteria:
- Age \< 18 years and \> 55 years.
- Patients receiving other antidepressants and dietary supplements in the last two months.
- Patients with other psychiatric disorders (such as anxiety disorder, schizophrenia, bipolar disorder, alcoholism).
Exclusion
Key Trial Info
Start Date :
September 15 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 20 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04482296
Start Date
September 15 2019
End Date
August 20 2020
Last Update
January 27 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
BSMMU
Dhaka, Bangladesh